# AMN Healthcare Services Inc: financial statements, quarterly

AMN · NYSE · CIK 1142750 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/amn.md) · [Financials](/companies/amn/financials.md) · [Filings](/companies/amn/filings.md) · [Insiders](/companies/amn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/amn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [853](/filings/0001142750-24-000061.md) | [818 d](/filings/0001628280-26-009918.md) | [821](/filings/0001142750-25-000034.md) | [741](/filings/0001142750-25-000052.md) | [688](/filings/0001628280-25-050362.md) | [735 d](/filings/0001628280-26-009918.md) | [690](/filings/0001628280-26-032419.md) | [658](/filings/0001628280-26-054507.md) | [634](/filings/0001628280-25-050362.md) | [748 d](/filings/0001628280-26-009918.md) | [1,378](/filings/0001628280-26-032419.md) | [673](/filings/0001628280-26-054507.md) |
| Cost of revenue | $m | [564](/filings/0001142750-24-000061.md) | [557 d](/filings/0001628280-26-009918.md) | [563](/filings/0001142750-25-000034.md) | [511](/filings/0001142750-25-000052.md) | [474](/filings/0001628280-25-050362.md) | [516 d](/filings/0001628280-26-009918.md) | [491](/filings/0001628280-26-032419.md) | [462](/filings/0001628280-26-054507.md) | [450](/filings/0001628280-25-050362.md) | [553 d](/filings/0001628280-26-009918.md) | [1,010](/filings/0001628280-26-032419.md) | [467](/filings/0001628280-26-054507.md) |
| Gross profit | $m | [290](/filings/0001142750-24-000061.md) | [261 d](/filings/0001628280-26-009918.md) | [258](/filings/0001142750-25-000034.md) | [230](/filings/0001142750-25-000052.md) | [213](/filings/0001628280-25-050362.md) | [219 d](/filings/0001628280-26-009918.md) | [198](/filings/0001628280-26-032419.md) | [196](/filings/0001628280-26-054507.md) | [184](/filings/0001628280-25-050362.md) | [195 d](/filings/0001628280-26-009918.md) | [369](/filings/0001628280-26-032419.md) | [206](/filings/0001628280-26-054507.md) |
| Selling, general and administrative | $m | [163](/filings/0001142750-24-000061.md) | [178 d](/filings/0001628280-26-009918.md) | [175](/filings/0001142750-25-000034.md) | [149](/filings/0001142750-25-000052.md) | [150](/filings/0001628280-25-050362.md) | [159 d](/filings/0001628280-26-009918.md) | [148](/filings/0001628280-26-032419.md) | [155](/filings/0001628280-26-054507.md) | [139](/filings/0001628280-25-050362.md) | [152 d](/filings/0001628280-26-009918.md) | [218](/filings/0001628280-26-032419.md) | [147](/filings/0001628280-26-054507.md) |
| Operating income | $m | [86.9](/filings/0001142750-24-000061.md) | [34.2 d](/filings/0001628280-26-009918.md) | [39.9](/filings/0001142750-25-000034.md) | [37.7](/filings/0001142750-25-000052.md) | [22.3](/filings/0001628280-25-050362.md) | [(203) d](/filings/0001628280-26-009918.md) | [12.5](/filings/0001628280-26-032419.md) | [(124)](/filings/0001628280-26-054507.md) | [47.6](/filings/0001628280-25-050362.md) | [8.1 d](/filings/0001628280-26-009918.md) | [117](/filings/0001628280-26-032419.md) | [26.9](/filings/0001628280-26-054507.md) |
| Interest expense | $m | [11.5](/filings/0001142750-23-000030.md) | [20.2 d](/filings/0001142750-24-000016.md) | [16.6](/filings/0001142750-24-000040.md) | [15.7](/filings/0001142750-25-000052.md) | [14.4](/filings/0001628280-25-050362.md) | [23.1 d](/filings/0001628280-26-009918.md) | [12.3](/filings/0001628280-26-032419.md) | [11.4](/filings/0001628280-26-054507.md) | [9.6](/filings/0001628280-25-050362.md) | [12.3 d](/filings/0001628280-26-009918.md) | [6.7](/filings/0001628280-26-032419.md) | [7.0](/filings/0001628280-26-054507.md) |
| Income tax | $m | [22.2](/filings/0001142750-24-000061.md) | [1.5 d](/filings/0001628280-26-009918.md) | [6.0](/filings/0001142750-25-000034.md) | [5.7](/filings/0001142750-25-000052.md) | [0.8](/filings/0001628280-25-050362.md) | [(38.1) d](/filings/0001628280-26-009918.md) | [1.3](/filings/0001628280-26-032419.md) | [(18.9)](/filings/0001628280-26-054507.md) | [8.7](/filings/0001628280-25-050362.md) | [3.5 d](/filings/0001628280-26-009918.md) | [48.3](/filings/0001628280-26-032419.md) | [(1.3)](/filings/0001628280-26-054507.md) |
| Net income | $m | [53.2](/filings/0001142750-24-000061.md) | [12.5 d](/filings/0001628280-26-009918.md) | [17.3](/filings/0001142750-25-000034.md) | [16.2](/filings/0001142750-25-000052.md) | [7.0](/filings/0001628280-25-050362.md) | [(188) d](/filings/0001628280-26-009918.md) | [(1.1)](/filings/0001628280-26-032419.md) | [(116)](/filings/0001628280-26-054507.md) | [29.3](/filings/0001628280-25-050362.md) | [(7.7) d](/filings/0001628280-26-009918.md) | [62.2](/filings/0001628280-26-032419.md) | [21.2](/filings/0001628280-26-054507.md) |
| Diluted EPS | $ per share | [1.39](/filings/0001142750-24-000061.md) | not reported | [0.45](/filings/0001142750-25-000034.md) | [0.42](/filings/0001142750-25-000052.md) | [0.18](/filings/0001628280-25-050362.md) | not reported | [(0.03)](/filings/0001628280-26-032419.md) | [(3.02)](/filings/0001628280-26-054507.md) | [0.76](/filings/0001628280-25-050362.md) | not reported | [1.59](/filings/0001628280-26-032419.md) | [0.53](/filings/0001628280-26-054507.md) |
| Basic EPS | $ per share | [1.39](/filings/0001142750-24-000061.md) | not reported | [0.45](/filings/0001142750-25-000034.md) | [0.43](/filings/0001142750-25-000052.md) | [0.18](/filings/0001628280-25-050362.md) | not reported | [(0.03)](/filings/0001628280-26-032419.md) | [(3.02)](/filings/0001628280-26-054507.md) | [0.76](/filings/0001628280-25-050362.md) | not reported | [1.60](/filings/0001628280-26-032419.md) | [0.54](/filings/0001628280-26-054507.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [29.4](/filings/0001142750-23-000030.md) | [32.9](/filings/0001142750-25-000011.md) | [50.6](/filings/0001142750-24-000040.md) | [48.0](/filings/0001142750-24-000050.md) | [30.6](/filings/0001142750-24-000061.md) | [10.6](/filings/0001628280-26-009918.md) | [55.8](/filings/0001142750-25-000034.md) | [41.5](/filings/0001142750-25-000052.md) | [52.6](/filings/0001628280-25-050362.md) | [34.0](/filings/0001628280-26-054507.md) | [561](/filings/0001628280-26-032419.md) | [362](/filings/0001628280-26-054507.md) |
| Current assets | $m | [831](/filings/0001142750-23-000030.md) | [842](/filings/0001142750-25-000011.md) | [791](/filings/0001142750-24-000040.md) | [705](/filings/0001142750-24-000050.md) | [612](/filings/0001142750-24-000061.md) | [595](/filings/0001628280-26-009918.md) | [627](/filings/0001142750-25-000034.md) | [571](/filings/0001142750-25-000052.md) | [570](/filings/0001628280-25-050362.md) | [545](/filings/0001628280-26-054507.md) | [1,137](/filings/0001628280-26-032419.md) | [869](/filings/0001628280-26-054507.md) |
| Total assets | $m | [2,655](/filings/0001142750-23-000030.md) | [2,924](/filings/0001142750-25-000011.md) | [2,874](/filings/0001142750-24-000040.md) | [2,771](/filings/0001142750-24-000050.md) | [2,668](/filings/0001142750-24-000061.md) | [2,416](/filings/0001628280-26-009918.md) | [2,395](/filings/0001142750-25-000034.md) | [2,212](/filings/0001142750-25-000052.md) | [2,139](/filings/0001628280-25-050362.md) | [2,094](/filings/0001628280-26-054507.md) | [2,604](/filings/0001628280-26-032419.md) | [2,364](/filings/0001628280-26-054507.md) |
| Current liabilities | $m | [707](/filings/0001142750-23-000030.md) | [656](/filings/0001142750-25-000011.md) | [624](/filings/0001142750-24-000040.md) | [574](/filings/0001142750-24-000050.md) | [519](/filings/0001142750-24-000061.md) | [546](/filings/0001628280-26-009918.md) | [582](/filings/0001142750-25-000034.md) | [574](/filings/0001142750-25-000052.md) | [542](/filings/0001628280-25-050362.md) | [578](/filings/0001628280-26-054507.md) | [1,044](/filings/0001628280-26-032419.md) | [770](/filings/0001628280-26-054507.md) |
| Total liabilities | $m | [1,838](/filings/0001142750-23-000030.md) | [2,093](/filings/0001142750-25-000011.md) | [2,019](/filings/0001142750-24-000040.md) | [1,894](/filings/0001142750-24-000050.md) | [1,777](/filings/0001142750-24-000061.md) | [1,709](/filings/0001628280-26-009918.md) | [1,680](/filings/0001142750-25-000034.md) | [1,605](/filings/0001142750-25-000052.md) | [1,495](/filings/0001628280-25-050362.md) | [1,452](/filings/0001628280-26-054507.md) | [1,892](/filings/0001628280-26-032419.md) | [1,623](/filings/0001628280-26-054507.md) |
| Long-term debt | $m | not reported | [1,305](/filings/0001142750-25-000011.md) | not reported | not reported | not reported | [1,056](/filings/0001628280-26-009918.md) | not reported | not reported | not reported | [767](/filings/0001628280-26-009918.md) | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [817](/filings/0001142750-24-000061.md) | [831](/filings/0001628280-26-009918.md) | [854](/filings/0001628280-25-050362.md) | [877](/filings/0001628280-25-050362.md) | [891](/filings/0001628280-25-050362.md) | [707](/filings/0001628280-26-054507.md) | [715](/filings/0001628280-26-054507.md) | [608](/filings/0001628280-26-054507.md) | [644](/filings/0001628280-25-050362.md) | [642](/filings/0001628280-26-054507.md) | [713](/filings/0001628280-26-054507.md) | [741](/filings/0001628280-26-054507.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [172 d](/filings/0001142750-24-000061.md) | [(41.1) d](/filings/0001628280-26-009918.md) | [81.4](/filings/0001142750-25-000034.md) | [99.5 d](/filings/0001142750-25-000052.md) | [66.7 d](/filings/0001628280-25-050362.md) | [72.8 d](/filings/0001628280-26-009918.md) | [92.7](/filings/0001628280-26-032419.md) | [78.5 d](/filings/0001628280-26-054507.md) | [22.7 d](/filings/0001628280-25-050362.md) | [75.6 d](/filings/0001628280-26-009918.md) | [562](/filings/0001628280-26-032419.md) | [(190) d](/filings/0001628280-26-054507.md) |
| Capital expenditure | $m | [29.9 d](/filings/0001142750-24-000061.md) | [29.9 d](/filings/0001628280-26-009918.md) | [18.1](/filings/0001142750-25-000034.md) | [27.3 d](/filings/0001142750-25-000052.md) | [19.3 d](/filings/0001628280-25-050362.md) | [16.2 d](/filings/0001628280-26-009918.md) | [10.0](/filings/0001628280-26-032419.md) | [9.8 d](/filings/0001628280-26-054507.md) | [7.9 d](/filings/0001628280-25-050362.md) | [7.9 d](/filings/0001628280-26-009918.md) | [7.2](/filings/0001628280-26-032419.md) | [8.5 d](/filings/0001628280-26-054507.md) |
| Share repurchases | $m | [0.0 d](/filings/0001142750-24-000061.md) | [0.0 d](/filings/0001628280-26-009918.md) | [0.0](/filings/0001142750-24-000040.md) | [0.0 d](/filings/0001142750-24-000050.md) | [0.0 d](/filings/0001142750-24-000061.md) | [0.0 d](/filings/0001628280-26-009918.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [44.0](/filings/0001142750-23-000030.md) | [41.6](/filings/0001142750-24-000040.md) | [39.3](/filings/0001142750-24-000050.md) | [38.3](/filings/0001142750-24-000061.md) | [38.2](/filings/0001142750-25-000034.md) | [38.2](/filings/0001142750-25-000052.md) | [38.3](/filings/0001628280-25-050362.md) | [38.3](/filings/0001628280-26-032419.md) | [38.4](/filings/0001628280-26-054507.md) | [38.7](/filings/0001628280-25-050362.md) | [39.1](/filings/0001628280-26-032419.md) | [39.7](/filings/0001628280-26-054507.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,729,991 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054507.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.